Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

Sanofi names François-Xavier Roger as new CFO

EditorNatashya Angelica
Published 01/02/2024, 09:00
Updated 01/02/2024, 09:00
© Reuters.

PARIS - Sanofi (NASDAQ:SNY), the global healthcare leader, announced today that François-Xavier Roger will take over as Chief Financial Officer and join its Executive Committee starting April 1, 2024. Roger, who will be based in Paris, succeeds Jean-Baptiste Chasseloup de Chatillon, as he steps into a new role as Head of Apprentis d’Auteuil, a charitable foundation.

Roger brings a wealth of experience to Sanofi, having served as CFO at Nestle for more than eight years. His tenure there was marked by strong financial leadership and a commitment to sustainable value creation. Roger's extensive international experience includes positions across Europe, the U.S., Asia, Africa, and Latin America. Prior to Nestle, he was the CFO of Takeda Pharmaceuticals in Japan from 2013 to 2015. His career in the pharmaceutical industry began with a 14-year stint at Roussel, Hoechst, and Aventis, followed by roles at Danone Asia and the Danone Group, and later as CFO of Millicom, a NASDAQ-listed mobile phone operator.

Sanofi's CEO, Paul Hudson (NYSE:HUD), expressed confidence in Roger's appointment, noting his proven track record and the anticipated contribution to Sanofi's next phase of growth. Hudson also acknowledged the outgoing CFO, Chasseloup de Chatillon, for his role in advancing Sanofi's "Play to Win Strategy" and modernizing the finance organization.

Chasseloup de Chatillon reflected positively on his tenure at Sanofi, highlighting the company's transformation and his decision to join Apprentis d’Auteuil, driven by a passion for social impact. Roger, in turn, expressed enthusiasm for joining Sanofi during a significant period of transformation, aiming to enhance patient outcomes and shareholder value.

Sanofi is known for its commitment to improving lives through science, offering treatment options and vaccine protection globally. The company emphasizes sustainability and social responsibility in its operations. Sanofi's stock is traded on EURONEXT under the ticker SAN and on NASDAQ under the ticker SNY.

This leadership transition at Sanofi is based on a press release statement from the company.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.